Utilization of HCV Viremic Kidneys with Genotyping/Subtyping-Free Sofosbuvir/Velpatasvir Treatment Strategy: Experience from China

Figure 1

Posttransplant ALT tests in HCV D+/R- group and D+/R+ group.